Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacco de Haan

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Critical Care Medicine|August 2, 2007
Are we finally taming inflammation?Misha Luyer, Jan Willem Greve, Jacco de Haan, et al.
Journal of Neuroinflammation|July 9, 2021
Acute pre-operative ibuprofen improves cognition in a rat model for postoperative cognitive dysfunctionKlaske Oberman, Iris Hovens, Jacco de Haan, et al.
Therapeutic Drug Monitoring|June 7, 2019
Reversible Impaired Methotrexate Clearance After Platinum-Based Chemotherapy for OsteosarcomaThijs Oude Munnink, Alex van der Meer, Jacco de Haan, et al.
European Journal of Cancer (Oxford, England : 1990)|June 1, 2021
Randomised phase 2 study comparing the efficacy and safety of the oral tyrosine kinase inhibitor nintedanib with single agent ifosfamide in patients with advanced, inoperable, metastatic soft tissue sarcoma after failure of first-line chemotherapy: EORTC-1506-STBSG "ANITA"Patrick Schöffski, Maud Toulmonde, Anna Estival, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Critical Care Medicine|August 2, 2007
Are we finally taming inflammation?Misha Luyer, Jan Willem Greve, Jacco de Haan, et al.
Journal of Neuroinflammation|July 9, 2021
Acute pre-operative ibuprofen improves cognition in a rat model for postoperative cognitive dysfunctionKlaske Oberman, Iris Hovens, Jacco de Haan, et al.
Therapeutic Drug Monitoring|June 7, 2019
Reversible Impaired Methotrexate Clearance After Platinum-Based Chemotherapy for OsteosarcomaThijs Oude Munnink, Alex van der Meer, Jacco de Haan, et al.
European Journal of Cancer (Oxford, England : 1990)|June 1, 2021
Randomised phase 2 study comparing the efficacy and safety of the oral tyrosine kinase inhibitor nintedanib with single agent ifosfamide in patients with advanced, inoperable, metastatic soft tissue sarcoma after failure of first-line chemotherapy: EORTC-1506-STBSG "ANITA"Patrick Schöffski, Maud Toulmonde, Anna Estival, et al.
Pageof 1